Vik Chopra

Stock Analyst at Wells Fargo

(1.84)
# 3,142
Out of 4,893 analysts
41
Total ratings
35.29%
Success rate
-3.81%
Average return

Stocks Rated by Vik Chopra

Masimo
May 7, 2025
Maintains: Overweight
Price Target: $205$190
Current: $165.41
Upside: +14.87%
Integra LifeSciences Holdings
May 6, 2025
Maintains: Equal-Weight
Price Target: $25$13
Current: $13.05
Upside: -0.38%
Henry Schein
May 6, 2025
Maintains: Equal-Weight
Price Target: $80$75
Current: $74.14
Upside: +1.16%
CONMED
May 1, 2025
Maintains: Equal-Weight
Price Target: $70$57
Current: $52.91
Upside: +7.73%
Align Technology
May 1, 2025
Maintains: Overweight
Price Target: $255$246
Current: $200.48
Upside: +22.71%
Solventum
Feb 28, 2025
Maintains: Equal-Weight
Price Target: $73$75
Current: $74.19
Upside: +1.09%
DENTSPLY SIRONA
Feb 28, 2025
Maintains: Equal-Weight
Price Target: $20$19
Current: $16.57
Upside: +14.67%
Globus Medical
Feb 21, 2025
Maintains: Overweight
Price Target: $95$93
Current: $57.31
Upside: +62.28%
Envista Holdings
Feb 6, 2025
Maintains: Equal-Weight
Price Target: $20$21
Current: $20.38
Upside: +3.04%
NeuroPace
Nov 13, 2024
Maintains: Overweight
Price Target: $15$13
Current: $10.08
Upside: +28.97%
Maintains: Overweight
Price Target: $26$19
Current: $11.49
Upside: +65.36%
Maintains: Overweight
Price Target: $73$79
Current: $35.56
Upside: +122.16%